Owen A - Search Results

1

Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study.

Dickinson L, Amin J, Else L, Boffito M, Egan D, Owen A, Khoo S, Back D, Orrell C, Clarke A, Losso M, Phanuphak P, Carey D, Cooper DA, Emery S, Puls R; ENCORE1 Study Group. Dickinson L, et al. Among authors: owen a. Clin Pharmacol Ther. 2015 Oct;98(4):406-16. doi: 10.1002/cpt.156. Epub 2015 Jul 14. Clin Pharmacol Ther. 2015. PMID: 26044067 Free PMC article. Clinical Trial.

2

A simplified approach to determining P-glycoprotein expression in peripheral blood mononuclear cell subsets.

Ford J, Hoggard PG, Owen A, Khoo SH, Back DJ. Ford J, et al. Among authors: owen a. J Immunol Methods. 2003 Mar 1;274(1-2):129-37. doi: 10.1016/s0022-1759(02)00509-4. J Immunol Methods. 2003. PMID: 12609539

3

The effects of protease inhibitors and nonnucleoside reverse transcriptase inhibitors on p-glycoprotein expression in peripheral blood mononuclear cells in vitro.

Chandler B, Almond L, Ford J, Owen A, Hoggard P, Khoo S, Back D. Chandler B, et al. Among authors: owen a. J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):551-6. doi: 10.1097/00126334-200308150-00001. J Acquir Immune Defic Syndr. 2003. PMID: 12902797

4

Functional correlation of P-glycoprotein expression and genotype with expression of the human immunodeficiency virus type 1 coreceptor CXCR4.

Owen A, Chandler B, Bray PG, Ward SA, Hart CA, Back DJ, Khoo SH. Owen A, et al. J Virol. 2004 Nov;78(21):12022-9. doi: 10.1128/JVI.78.21.12022-12029.2004. J Virol. 2004. PMID: 15479841 Free PMC article.

5

Expression of pregnane-X-receptor transcript in peripheral blood mononuclear cells and correlation with MDR1 mRNA.

Owen A, Chandler B, Back DJ, Khoo SH. Owen A, et al. Antivir Ther. 2004 Oct;9(5):819-21. Antivir Ther. 2004. PMID: 15535420

6

Intracellular pharmacokinetics of antiretroviral agents.

Owen A, Khoo SH. Owen A, et al. J HIV Ther. 2004 Nov;9(4):97-101. J HIV Ther. 2004. PMID: 15731742 Review.

7

The implications of P-glycoprotein in HIV: friend or foe?

Owen A, Chandler B, Back DJ. Owen A, et al. Fundam Clin Pharmacol. 2005 Jun;19(3):283-96. doi: 10.1111/j.1472-8206.2005.00324.x. Fundam Clin Pharmacol. 2005. PMID: 15910652 Review.

8

In vitro synergy and enhanced murine brain penetration of saquinavir coadministered with mefloquine.

Owen A, Janneh O, Hartkoorn RC, Chandler B, Bray PG, Martin P, Ward SA, Hart CA, Khoo SH, Back DJ. Owen A, et al. J Pharmacol Exp Ther. 2005 Sep;314(3):1202-9. doi: 10.1124/jpet.105.086272. Epub 2005 May 27. J Pharmacol Exp Ther. 2005. PMID: 15923343

9

Host determinants of antiretroviral drug activity.

Boffito M, Winston A, Owen A. Boffito M, et al. Among authors: owen a. Curr Opin Infect Dis. 2005 Dec;18(6):543-9. doi: 10.1097/01.qco.0000191507.48481.10. Curr Opin Infect Dis. 2005. PMID: 16258330 Review.

10

Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP.

Janneh O, Owen A, Chandler B, Hartkoorn RC, Hart CA, Bray PG, Ward SA, Back DJ, Khoo SH. Janneh O, et al. Among authors: owen a. AIDS. 2005 Dec 2;19(18):2097-102. doi: 10.1097/01.aids.0000194793.36175.40. AIDS. 2005. PMID: 16284458

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,547 results

Search Page

Filters